Prandin
Product Images NDC 68151-3566

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prandin (NDC 68151-3566). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig. 1 (Structural Formula of Prandin)

Fig. 1 (Structural Formula of Prandin)
FDA Label Image

Fig. 2 (Prandin Pioglitazone Combination Study)

Fig. 2 (Prandin Pioglitazone Combination Study)
FDA Label Image

Label Image (Lbl681513566)

Label Image (Lbl681513566)
The text is a medication label for Prandin (repaglinide) 1mg tablet manufactured by Novo Nordisk. It includes information on lot number, expiration date, and a unique identifier for the prescription.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.